[ad_1]
Wednesday, December 30, 2020, 10.42 am
FDA to expedite importation of COVID vaccine For Thais to use as soon as possible Many countries around the world have approved the vaccine and about 9 countries have used more than 4.4 million doses of the vaccine tested in humans In particular, the state has used 1.94 million doses. There are 26 million doses, and the government is working on more to make more vaccines available to everyone.
December 30, 2020 Dr. Surachok Tangwiwat, Assistant Secretary General of the Food and Drug Administration (FDA), revealed that due to the global epidemic situation, many countries are in the process of developing vaccines. To be used to prevent COVID-19 Urgently In Thailand in the process of developing a vaccine. There are six vaccines in the WHO announcement, of which three are available from three different agencies. The initial immunosuppressive effects in laboratory animals were satisfactory. And plan to continue researching in humans
Regarding the vaccine in foreign research and development If there is successful research on people It is safe and effective in treating COVID-19, FDA insists to supply such vaccine to Thailand soon. Ask people not to worry about the COVID-19 drug. That many countries around the world are used now, including the Xivier remedy. And Japhavipiravir In Thailand, the above drugs have been imported and both drug formulations have been registered by the FDA.
Additionally, the Government Pharmaceutical Organization is in the process of developing favipiravir tablets. The registration application is expected to be submitted by 2021 for use in treating COVID-19. However, the FDA is willing to support the vaccine registry in an urgent situation. This includes expediting the evaluation of vaccine production sites to meet good standards for drug production. Be prepared for clinical research and production for proper distribution. Adhering to the principle of speed while adhering to correct academic principles Efficient And most importantly, it must be safe. Rest assured the FDA operation and Thais should receive the COVID-19 vaccine With the country leading the production course
The newspaper reports that 9 countries have used more than 4.4 million doses of Novak Covid-19
Professor Dr. Sirirerk Songsivilai, Permanent Secretary of the Ministry of Higher Education, Science, Research and Innovation (RAIS) revealed the progress of the research and development of the COVID-19 vaccine. That a COVID-19 vaccine currently exists.Many species have undergone human testing to ensure that they are effective and safe enough. And it has been approved in many countries of the world. It has been used in approximately nine countries, including more than 4.4 million doses, particularly in the United States, the first inoculation of the population began on December 14, 2020, with more than 1.94 million doses of assigned vaccine. 5.1 million doses of Pfizer / BioNtech and 6 million doses of Moderna vaccine, which must be administered in two doses each. The test results are effective in preventing COVID-19. More than 95 percent
With regard to the procurement and preparation of vaccines, countries around the world have agreed to pre-reserve 8.15 billion doses from each manufacturer, covering approximately half of the world’s population. Since most of the vaccine is given in 2 doses per person, the vaccine has already been reserved for 4.075 million people and deliveries started from now until 2022. AstraZeneca was the first company. That it reached an agreement for the advance subscription of vaccines for the world population. Which one currently has more stocks? This equates to roughly 1.46 billion people, more than double the number of third-party vaccines, while some are not tested, like the Australian vaccine that had to cancel testing on December 10, 2020, and more late Sanofi and GlaxoSmithKline. He also announced delaying vaccine testing
COVID-19 Vaccine Comes to Market at Record Speed Vaccine development typically takes years. This is because the world has supported accelerated research and development of multiple vaccines simultaneously and shortened splicing time during each stage of testing, manufacturing, and registration. Professor Siriruek Please provide additional information that The number of vaccines being evaluated for efficacy is increasing. And each manufacturer has rapidly increased the number of production. Enough vaccines are expected for high-risk groups early next year. And in the second half of 2021, most people who should be vaccinated will have access to this vaccine.
Professor Siriruek Point out that there are a variety of countries’ vaccine access strategies, such as bilateral agreements with individual manufacturers. Or how do dozens of countries have multilateral agreements through the COVAX mechanism or the World Health Organization? To ensure that the vaccine is distributed evenly. However, the number of pre-orders for vaccines varies from country to country; For example, Canada, which has 38 million people, has vaccination contracts with at least seven companies to supply enough vaccines to inject 112 million people, three times the country’s population. Many times Including the UK, Australia, the US, France, Italy, Japan, Mexico already ordered more vaccines than the population. While other countries Around 0-20% of the population has been reserved for vaccines in Thailand, 26 million doses have been reserved and the government is working on more to make more vaccines available to all. Both by national production Acquired from each manufacturer and research and develop vaccines also in the country.
“RAIS has closely monitored the vaccine situation every day coordinating with the CRC and the Ministry of Public Health. Oversee technical support, research and technology for vaccine production. And this unprecedented rapid development of the new global coronavirus vaccine. It is very rewarding. Every vaccine that is evaluated Good performance Tested, it is safe. It can boost the immune system AND prevent infection well Including researchers from around the world to monitor the epidemic situation. Mutation Y will develop several vaccines to be more efficient and effective, ”said the Permanent Secretary of the Ministry of Education.
Singapore begins COVID-19 vaccination The first batch of healthcare personnel
Singapore Ministry of Health said today (December 30) more than 30 health personnel from the National Center for Communicable Diseases. He was the first person from Singapore to receive the Pfizer COVID-19 vaccine from Sarah Lim National Center for Communicable Diseases Senior Nurse Sarah Lim. Be the first person to get vaccinated
American soldiers in South Korea have received their first vaccination.
Officials from the USFK in South Korea, or USFK, said the USFK included military personnel. Other personnel AND around 28,500 military family members have been vaccinated against COVID-19. First dose for health professionals and people loaded with COVID-19 From us FK already
The USFK commander said: The rest of the USFK personnel will also be vaccinated against COVID-19, while the South Korean authorities plan to start vaccination against COVID-19. February of this species is first injected into medical workers and vulnerable people. But the government has been criticized for saying The calendar was several months behind the US and the EU. US forces in Japan began the first vaccination at Yokota Air Base on Monday.
“Wuhan” started the COVID-19 vaccination. Delivered to the NACC in risk groups
The Xinhua news agency reported that the Wuhan government said the capital city of the Chinese province of Hubei. Wuhan has started vaccination against COVID-19. It is an emergency for the vulnerable population.
He Zhen Yu, deputy director of the Wuhan Center for Disease Control and Prevention, said: Wuhan authorities began vaccinating vulnerable people aged 18 to 59 years from December 24 at 48 special clinics in 15 districts of the city, where they will be vaccinated against COVID-19. 2 doses, each 4 weeks apart
Peng Hou Peng, deputy director of the Wuhan Health Committee. Wuhan detects COVID-19 patients From abroad, 43 cases accumulated between October 1 and December 27, divided into 10 confirmed patients and 33 asymptomatic patients. With the exception of 4 asymptomatic patients, they have been discharged from the hospital.
[ad_2]